For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
12
views
39
references
 Top references
cited by
27
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      145
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The effect of a pharmacy-led transitional care program on medication-related problems post-discharge: A before-After prospective study.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Medication-related problems are common after hospitalization, for example when changes in patients' medication regimens are accompanied by insufficient patient education, poor information transfer between healthcare providers, and inadequate follow-up post-discharge. We investigated the effect of a pharmacy-led transitional care program on the occurrence of medication-related problems four weeks post-discharge.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          Role of pharmacist counseling in preventing adverse drug events after hospitalization.

          C. Roy, Allen Kachalia, M Horng … (2006)
          Hospitalization and subsequent discharge home often involve discontinuity of care, multiple changes in medication regimens, and inadequate patient education, which can lead to adverse drug events (ADEs) and avoidable health care utilization. Our objectives were to identify drug-related problems during and after hospitalization and to determine the effect of patient counseling and follow-up by pharmacists on preventable ADEs. We conducted a randomized trial of 178 patients being discharged home from the general medicine service at a large teaching hospital. Patients in the intervention group received pharmacist counseling at discharge and a follow-up telephone call 3 to 5 days later. Interventions focused on clarifying medication regimens; reviewing indications, directions, and potential side effects of medications; screening for barriers to adherence and early side effects; and providing patient counseling and/or physician feedback when appropriate. The primary outcome was rate of preventable ADEs. Pharmacists observed the following drug-related problems in the intervention group: unexplained discrepancies between patients' preadmission medication regimens and discharge medication orders in 49% of patients, unexplained discrepancies between discharge medication lists and postdischarge regimens in 29% of patients, and medication nonadherence in 23%. Comparing trial outcomes 30 days after discharge, preventable ADEs were detected in 11% of patients in the control group and 1% of patients in the intervention group (P = .01). No differences were found between groups in total ADEs or total health care utilization. Pharmacist medication review, patient counseling, and telephone follow-up were associated with a lower rate of preventable ADEs 30 days after hospital discharge. Medication discrepancies before and after discharge were common targets of intervention.
          Article 0 comments Cited 172 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            National surveillance of emergency department visits for outpatient adverse drug events.

            Daniel S Budnitz, Daniel A Pollock, Kelly Weidenbach … (2006)
            Adverse drug events are common and often preventable causes of medical injuries. However, timely, nationally representative information on outpatient adverse drug events is limited. To describe the frequency and characteristics of adverse drug events that lead to emergency department visits in the United States. Active surveillance from January 1, 2004, through December 31, 2005, through the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project. National estimates of the numbers, population rates, and severity (measured by hospitalization) of individuals with adverse drug events treated in emergency departments. Over the 2-year study period, 21,298 adverse drug event cases were reported, producing weighted annual estimates of 701,547 individuals (95% confidence interval [CI], 509,642-893,452) or 2.4 individuals per 1000 population (95% CI, 1.7-3.0) treated in emergency departments. Of these cases, 3487 individuals required hospitalization (annual estimate, 117,318 [16.7%]; 95% CI, 13.1%-20.3%). Adverse drug events accounted for 2.5% (95% CI, 2.0%-3.1%) of estimated emergency department visits for all unintentional injuries and 6.7% (95% CI, 4.7%-8.7%) of those leading to hospitalization and accounted for 0.6% of estimated emergency department visits for all causes. Individuals aged 65 years or older were more likely than younger individuals to sustain adverse drug events (annual estimate, 4.9 vs 2.0 per 1000; rate ratio [RR], 2.4; 95% CI, 1.8-3.0) and more likely to require hospitalization (annual estimate, 1.6 vs 0.23 per 1000; RR, 6.8; 95% CI, 4.3-9.2). Drugs for which regular outpatient monitoring is used to prevent acute toxicity accounted for 41.5% of estimated hospitalizations overall (1381 cases; 95% CI, 30.9%-52.1%) and 54.4% of estimated hospitalizations among individuals aged 65 years or older (829 cases; 95% CI, 45.0%-63.7%). Adverse drug events among outpatients that lead to emergency department visits are an important cause of morbidity in the United States, particularly among individuals aged 65 years or older. Ongoing, population-based surveillance can help monitor these events and target prevention strategies.
            Article 0 comments Cited 160 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of an In-Hospital Multifaceted Clinical Pharmacist Intervention on the Risk of Readmission

              Jesper Hallas, Anton Pottegård, Lene Vestergaard Ravn-Nielsen … (2018)
              Hospital readmissions are common among patients receiving multiple medications, with considerable costs to the patients and society.
              Article 0 comments Cited 94 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (iso-abbrev): PLoS One
                Title: PloS one
                Publisher: Public Library of Science (PLoS)
                ISSN (Electronic): 1932-6203
                ISSN (Print): 1932-6203
                Publication date (Electronic): 2019
                Volume: 14
                Issue: 3
                Affiliations
                [1 ] Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands.
                [2 ] Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, the Netherlands.
                [3 ] Department of Internal Medicine, section of Geriatric Medicine, Academic Medical Center, Amsterdam, the Netherlands.
                [4 ] Department of Clinical Pharmacology & Pharmacy, VU University Medical Center, Amsterdam, the Netherlands.
                [5 ] Community Pharmacy Westwijk, Amsterdam, the Netherlands.
                [6 ] Department of General Practice, Academic Medical Center, Amsterdam, the Netherlands.
                [7 ] Department of Pharmacy, Sint Maartenskliniek, Nijmegen, the Netherlands.
                [8 ] Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands.
                [9 ] Department of Pharmacy, University Medical Centre Maastricht, the Netherlands.
                [10 ] Department of Cardiology, Academic Medical Center, Amsterdam, the Netherlands.
                [11 ] Department of Hospital Pharmacy, BovenIJ Hospital, Amsterdam, the Netherlands.
                Article
                Publisher Item ID: PONE-D-18-24125
                DOI: 10.1371/journal.pone.0213593
                PMC ID: 6413946
                PubMed ID: 30861042
                SO-VID: a8e62fd5-7577-4b91-9255-b931f4ccc018
                History

                Data availability:

                Comments

                Comment on this article

                scite_

                Similar content145

                See all similar

                Cited by27

                See all cited by

                Most referenced authors640

                See all reference authors